With Americans focused on getting fit in the new year, a groundbreaking new option is set to shift the weight loss landscape with two pharmaceutical giants both preparing to debut their oral GLP-1 options. The FDA approved Novo Nordisk’s once-daily Wegovy pill last week and Eli Lilly is awaiting FDA approval on its pill that saw adults lost 27 pounds over 72 weeks. NBC’s Maggie Vespa reports for TODAY.
